BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Press Releases

  Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors

  May 24, 2026

   · 

  13 min read
• Press Releases

  Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings

  May 24, 2026

   · 

  1 min read
• Press Releases

  ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting

  May 24, 2026

   · 

  4 min read
• Press Releases

  Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 22, 2026

  May 24, 2026

   · 

  2 min read
• Press Releases

  DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates

  May 24, 2026

   · 

  19 min read
• Press Releases

  Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates

  May 24, 2026

   · 

  19 min read
• Press Releases

  PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026

  May 24, 2026

   · 

  9 min read
• Press Releases

  Guerbet: Changes to the Composition of Guerbet’s Board of Directors.

  May 24, 2026

   · 

  4 min read
• Press Releases

  Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

  May 24, 2026

   · 

  8 min read
• Press Releases

  Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch

  May 24, 2026

   · 

  6 min read